A Nigerian scientist, Stella Babatope, has been recognised for her groundbreaking work at Babcock University and her current endeavours in global research and development in healthcare and cancer treatment.
Babatope undertook a research initiative to address the critical yet underexplored issue of contraceptive abuse.
Her study focused on the physiological and biological effects of prolonged, unregulated contraceptive use and investigated the therapeutic properties of a medicinal mushroom widely regarded for its healing potential in Asia.
Reflecting on her work, Babatope said, “I saw an opportunity to address a health issue that affects countless women but often goes unspoken. My goal was to provide solutions that balance contraceptive efficacy with minimising harmful side effects. It was both a scientific challenge and a personal mission to improve reproductive health management.”
Building on her foundational research on contraceptive use, she advanced to lead a pivotal study in the UK as a Research Associate, investigating the effects of hormonal replacement therapy on women transitioning through menopause.
This groundbreaking work explored how hormonal changes during this critical phase of life may predispose women to Alzheimer’s disease, providing valuable insights into the intersection of reproductive health and neurodegenerative disorders.
Her exceptional work in the field was able to win a grant from the NIHR UK initiative.
“Menopause is a widely recognized phenomenon, yet it remains poorly understood, even by the women experiencing it. Growing up, I noticed that menopause was a topic many women felt embarrassed to discuss, a reality that transcends cultural boundaries across the globe. It became essential for me to advocate for women’s health in later life and to explore ways to make this transition smoother and more manageable for women across economic class,” Babatope stated.
Babatope has now transitioned to cancer research at the University of Georgia, USA, as a Research Assistant, where she investigates resistance to anticancer therapies and explores better drug options for treating and managing pancreatic cancer.
“Pancreatic cancer is the third leading cause of cancer-related deaths in the United States, and it remains challenging to treat due to the lack of reliable diagnostic tools,” Babatope explained.
“My work focuses on exploring FDA-approved drugs and examining how combinations of these therapies can be used more effectively against pancreatic cancer cells. Understanding why treatments fail and finding ways to overcome these hurdles drives me. It’s about offering patients hope when they need it the most.”
Throughout her journey, Babatope has maintained a clear vision of science as a tool for societal impact. “Science isn’t just about discoveries or accolades,” she emphasised.
“It’s about creating solutions that matter to people. Whether in reproductive health, chronic diseases, or cancer, my goal has always been to ensure my work makes a tangible difference.”
In addition to her research, Babatope is a mentor to aspiring scientists and a passionate advocate for equitable education.
“Mentorship is critical. I want young scientists to know their ideas and voices matter. The future of science depends on their courage to ask questions and seek answers,” she said.
Babatope’s scientific prowess is a testament to the transformative power of research and the role science plays in improving lives.
With a relentless drive for excellence and a passion for advocacy, she is not only advancing the frontiers of knowledge but also inspiring a generation to use science as a force for good.
